Image credit: Bannard and Howarth. (2026) Despite the current public image challenges surrounding vaccines, progress in basic science and application continues to advance rapidly. A particularly significant...read more
Features and insights
When “Anonymous” Isn’t: The UK Biobank Data Exposure and the Limits of Health Data Privacy
The UK Biobank data exposure highlights a growing risk in modern health research: sensitive data is not only vulnerable to breaches, but to systemic leakage through normal scientific practices. This raises urgent...read more
From Surveys to Signals: How AI Is Changing Voice of the Customer in Life Sciences
From Surveys to Signals: How AI Is Changing Voice of the Customer in Life Sciences I’ve been spending some time thinking on how Voice of the Customer (VoC) programs are evolving as artificial intelligence (AI) becomes...read more
Tempus Scoops Up OneOme’s Pharmacogenetics Assets as Precision Medicine Shakeout Continues
Tempus AI has acquired the pharmacogenetics assets of OneOme, a once-promising precision medicine startup that abruptly shut down earlier this year amid financial troubles. The deal marks the latest in a flurry of...read more
New Therapy Potential of Targeted Protein Degradation
New approaches in drug discovery currently focus on the concept of a „magic bullet“ molecule. One that precisely targets an intended pharmacological role without off-target actions or unwanted side-effects. Traditional...read more
Stop Guessing. Start Diagnosing: The Marketing & Product-Market Fit Scorecard
I recently conducted a LinkedIn survey to understand why most startups fail. I asked “Most startups don’t fail because of a bad idea — they fail because founders ignore the warning signs. I’m curious — which of these do...read more
Why Are We Still Talking About Data Infrastructure for Life Sciences in 2025?
“In my twenty-five years in the Life Sciences industry, I’ve observed countless organizations adopt, revise, dismantle, and rebuild their data infrastructure.” While the rapid advancements of data technology certainly...read more
Why Most Startups Fail: The Brutal Truth and How to Beat the Odds
Launching a startup is exhilarating—a whirlwind of big ideas, bold moves, sleepless nights, and passionate pitches. But behind the scenes, the harsh reality remains: Most startups fail. Depending on which study you...read more
The Critical Link Between CROs and Sponsors: Making Data Work for You
Maximizing Focus, Minimizing Cost: The Strategic Logic of CRO Engagement Outsourcing to Contract Research Organizations (CROs) has been a fundamental practice in therapeutic and device discovery and early development...read more
Most Life Science Startups Hire Too Small. Here’s Why That’s a Costly Mistake
When early-stage biotech and digital health founders need to get to market, their instinct is to hire a junior marketer. It feels like the right first step: someone to manage social media, build a slide deck, maybe...read more
